SKAN Group AG (FRA:7VG) Total Equity: €136.7 Mil (As of Dec. 2025)


FRA:7VG SKAN Group AG FRA:7VG
62 GF Score
Price €59.00
GF Value €90.87
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is SKAN Group AG Total Equity?

SKAN Group AG FRA:7VG +2.61% 62 Total Equity is €136.7 Mil as of Dec. 2025. GuruFocus rates FRA:7VG with a GF Score™ of 62/100 and a GF Value™ of €90.87 (Significantly Undervalued). The stock has 6 warning signs investors should review.

SKAN Group AG's total equity for the quarter that ended in Dec. 2025 was €136.7 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

SKAN Group AG Total Equity Historical Data

* Premium members only.

The historical data trend for SKAN Group AG's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SKAN Group AG Total Equity Chart

SKAN Group AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 167.20 167.80 187.01 216.97 136.73

SKAN Group AG Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 187.01 185.65 216.97 195.57 136.73
FRA:7VG
62GF Score
SKAN Group AG FRA:7VG
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SKAN Group AG Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

SKAN Group AG's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=515.546-378.813
=136.7

SKAN Group AG's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=515.546-378.813
=136.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €136.7 Mil mean?
SKAN Group AG (FRA:7VG) has a Total Equity of €136.7 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for SKAN Group AG and its competitors.
Is SKAN Group AG's Total Equity too high?
SKAN Group AG's current Total Equity is €136.7 Mil. Overall, SKAN Group AG has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's Total Equity compare to ISRG and BDX?
SKAN Group AG's Total Equity of €136.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for SKAN Group AG and its competitors. SKAN Group AG's current Total Equity is €136.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
Based on GuruFocus' analysis, SKAN Group AG (FRA:7VG) is currently considered Significantly Undervalued. The stock's GF Value™ is €90.87, compared to a current price of €59.00 — trading 35.1% below its estimated fair value. The current Total Equity is €136.7 Mil. SKAN Group AG's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For SKAN Group AG (FRA:7VG), the current Total Equity is €136.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SKAN Group AG (FRA:7VG) Overvalued in 2026?

Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued. The current stock price of €59.00 is trading 35.1% below its estimated GF Value™ of €90.87. GuruFocus considers SKAN Group AG to be Significantly Undervalued.

Key valuation signals for FRA:7VG:

  • Total Equity: €136.7 Mil
  • GF Value™: €90.87 vs. price of €59.00 (35.1% below fair value)
  • GF Score™: 62/100 with 6 warning signs

No single metric tells the full story. See the FRA:7VG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SKAN Group AG Business Description

Address Kreuzstrasse 5, Allschwil, CHE, 4123
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
62GF Score

Get the complete analysis for FRA:7VG

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€59.00
Price
€90.87
GF Value